Literature DB >> 29226705

Survival prediction in pancreatic cancer patients with no distant metastasis: a large-scale population-based estimate.

Ning Pu1, Yang Lv1, Guochao Zhao1, Wanling Lee1, Abulimiti Nuerxiati1, Dansong Wang1, Xuefeng Xu1, Tiantao Kuang1, Wenchuan Wu1, Wenhui Lou1.   

Abstract

AIM: To identify the risk factors for overall survival (OS) of pancreatic ductal adenocarcinoma patients with no distant metastasis, and formulate a novel nomogram for prognostic prediction. PATIENTS &
METHODS: Data were obtained from Surveillance, Epidemiology, and End Results database of pancreatic ductal adenocarcinoma patients with no distant metastasis as the primary cohort, and 127 patients at our institution were enrolled as the validation cohort. The prognostic nomogram integrating all independent risk factors for predicting OS was established to achieve superior discriminatory ability.
RESULTS: The constructed nomogram showed excellent performance and superior predictive accuracy for OS according to the concordance index and calibration curve.
CONCLUSION: One more advanced and accurate predictive model will be obtained to assist in risk stratification via the constructed nomogram.

Entities:  

Keywords:  decision curve analysis; nomogram; pancreatic ductal adenocarcinoma; prognosis

Mesh:

Year:  2017        PMID: 29226705     DOI: 10.2217/fon-2017-0380

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  13 in total

1.  Prognostic Nomogram for Resected Pancreatic Adenocarcinoma: A TRIPOD-Compliant Retrospective Long-Term Survival Analysis.

Authors:  Dong Xu; Kai Zhang; Mingna Li; J P Neoptolemos; Junli Wu; Wentao Gao; Pengfei Wu; Baobao Cai; Jie Yin; Guodong Shi; Zipeng Lu; Kuirong Jiang; Yi Miao
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

2.  Chemoradiotherapy is associated with improved survival for resected pancreatic adenosquamous carcinoma: a retrospective cohort study from the SEER database.

Authors:  Yuan Fang; Ning Pu; Lei Zhang; Wenchuan Wu; Wenhui Lou
Journal:  Ann Transl Med       Date:  2019-10

3.  Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment.

Authors:  Chaobin He; Shuxin Sun; Yu Zhang; Xiaojun Lin; Shengping Li
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

4.  Nomograms for predicting overall survival and cancer-specific survival in young patients with pancreatic cancer in the US based on the SEER database.

Authors:  Min Shi; Biao Zhou; Shu-Ping Yang
Journal:  PeerJ       Date:  2020-04-14       Impact factor: 2.984

5.  Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction.

Authors:  Ning Pu; Hanlin Yin; Guochao Zhao; Abulimiti Nuerxiati; Dansong Wang; Xuefeng Xu; Tiantao Kuang; Dayong Jin; Wenhui Lou; Wenchuan Wu
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207

6.  A nomogram prediction of overall survival based on lymph node ratio, AJCC 8th staging system, and other factors for primary pancreatic cancer.

Authors:  Rui Zhong; Xin Jiang; Yan Peng; Huan Xu; Yongfeng Yan; Li Liu; Xiaowei Tang
Journal:  PLoS One       Date:  2021-05-05       Impact factor: 3.240

7.  Surveillance and management for serous cystic neoplasms of the pancreas based on total hazards-a multi-center retrospective study from China.

Authors:  Wenchuan Wu; Ji Li; Ning Pu; Gang Li; Xin Wang; Gang Zhao; Lei Wang; Xiaodong Tian; Chunhui Yuan; Yi Miao; Kuirong Jiang; Jun Cao; Xiaowu Xu; Xueli Bai; Yongsheng Yang; Fubao Liu; Xuewei Bai; Rui Kong; Zheng Wang; Deliang Fu; Wenhui Lou
Journal:  Ann Transl Med       Date:  2019-12

8.  Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis.

Authors:  Ning Pu; Jianang Li; Yaolin Xu; Wanling Lee; Yuan Fang; Xu Han; Guochao Zhao; Lei Zhang; Abulimiti Nuerxiati; Hanlin Yin; Wenchuan Wu; Wenhui Lou
Journal:  Cancer Manag Res       Date:  2018-02-05       Impact factor: 3.989

9.  The latest exploration of staging and prognostic classification for pancreatic neuroendocrine tumors: a large population-based study.

Authors:  Shanshan Gao; Ning Pu; Lingxiao Liu; Changyu Li; Xuefeng Xu; Xiaolin Wang; Wenhui Lou
Journal:  J Cancer       Date:  2018-04-19       Impact factor: 4.207

10.  CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.

Authors:  Ning Pu; Guochao Zhao; Hanlin Yin; Jian-Ang Li; Abulimiti Nuerxiati; Dansong Wang; Xuefeng Xu; Tiantao Kuang; Dayong Jin; Wenhui Lou; Wenchuan Wu
Journal:  J Transl Med       Date:  2018-10-25       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.